Already funded by the Megan’s Mission Foundation Childhood muscle cancer is rare but also unique among cancers – rhabdomyosarcoma not only mimics normal muscle stem
Already funded by the National Cancer Institute/National Institutes of Health! Alveolar rhabdomyosarcoma (aRMS) is generally not survivable when metastatic. However, this disease does respond to
It was a pleasure to send Dr. Keller to speak at the Summer’s Way rhabdomyosarcoma conference in Denver this past spring. Collaborator Dr. Mari Yohe
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Can we define a new standard of care for every subgroup of children battling aRMS? This project is important because many children, teens and young adults with alveolar rhabdomyosarcoma need new treatment options. When metastatic, the five-year survival rate is only 8%. We want aRMS to be universally survivable
Be the sponsor of this project! What if an FDA-approved dermatitis and asthma medicine could stop rhabdomyosarcoma metastasis? The major goal of this project is
Already funded by a collective of partner family foundations! Soft tissue sarcomas are among the top 5 causes of death from childhood cancer. Until now,
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
Already funded by the Megan’s Mission Foundation Childhood muscle cancer is rare but also unique among cancers – rhabdomyosarcoma not only mimics normal muscle stem
Already funded by the National Cancer Institute/National Institutes of Health! Alveolar rhabdomyosarcoma (aRMS) is generally not survivable when metastatic. However, this disease does respond to
It was a pleasure to send Dr. Keller to speak at the Summer’s Way rhabdomyosarcoma conference in Denver this past spring. Collaborator Dr. Mari Yohe
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Can we define a new standard of care for every subgroup of children battling aRMS? This project is important because many children, teens and young adults with alveolar rhabdomyosarcoma need new treatment options. When metastatic, the five-year survival rate is only 8%. We want aRMS to be universally survivable
Be the sponsor of this project! What if an FDA-approved dermatitis and asthma medicine could stop rhabdomyosarcoma metastasis? The major goal of this project is
Already funded by a collective of partner family foundations! Soft tissue sarcomas are among the top 5 causes of death from childhood cancer. Until now,
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute